lV-66 Circulation December 13, 2005 tained hypotensive ventricular tac Amiodarone 77. Somberg JC, Bailin SJ, Haffajee CI Paladino Wp. 99. Hedges JR, Syverud SA, Dalsey wC, Feero S, Easter R, Shultz B. Pre 98776:1337-1343 100. Barthel E. Troiano P, Olson D, Stueven HA, a prospective, controlled clinical Med.1988:17:1221-1 78. Somberg JC, Timar S, Bailin SJ, Lakatos F, Haffajee CI, Tarjan J Paladino en MP WP. Sarosi I. Kerin NZ, Borbola J, Bridges DE, Molnar J. Lack of J. Nicola RM. Horan S. Out-o aqueous f n.m下P3 V Engle med. 1993- 328: 1377-1382 lic card man S Cardoso LF 102. Stiell IG. Wells bert PC, Laupacis A, Weitzman BN. Association of drug therapy with survival in cardiac arrest: limited role of advanced lac life support drugs. Acad Emerg Med. 1995: 2: 264-273 103. Lindner KH. Ahnefeld FW. Bowd suscitation succe resuscitation in a pig model. Am J Emerg Ma.1919 during experimental myocardial infarction. Am j Cardiol.1976:37:860-863. 104. Befeler B. Mechanical stimulation of the heart; its therapeutic value in fibrillation threshold in the dog during acute ischemia and prematur Allege R, Arnberg 公Am)90边 heart stimulation ngI J Med.1974291:1324-13 fence of the precordial thump and cough version. BMJ. 1985 83. Herlitz J, Bang A, Holmberg M, Axelsson A. Lindkvist J. Holmberg S. 107. Morgera T, Baldi N, Chersevani D, Medugno G, Camerini F Chest thump elation to delay until 108. Rahner E, Z chlag ycardias by 84. Kentsch M. Berkel H. Bleifeld w. Intravenose Amio plication bei 85. Weaver WD. Fahrenbruch CE. Johnson DD, Hallstrom AP, Cobb LA. 109. Gertsch M, Hottinger S, Hess T. Serial chest thumps for the treatment of ar tachycardia in patients with coronary artery disease. Clin I11. Sclarovsky S, Kracoff OH, Agmon J. Acceleration of ventricular magnesium in recurrent persistent ventricular tachycardia. New Trends in Tzivoni D. Banai S, Schuger C, Benhorin J, Keren A, Gottlieb S, Stern S. Treatment of torsade de pointes with magnesium sulfate. Circulation 113. Thel MC, Armstrong AL. McNulty SE, Califf RM, O"Connor CM. R: von D. Gavish D. Levi Gottlieb S. Benhonin J. Stern sspitazcarzz6 amrest. Duke Etiology, warning signs and therapy of torsade de pointes: a study of 10 I 14. Allegra J, Lavery R, Cody R, Birnbaum G. Brennan J, Har atients. Circulation. 1981: 64 Bode C, Kern S Gries A, Gust R, Glatzer R. Bauer H ctory ventricular fibrillation in the prehospital setting itially unsuccessful cardiopulmonary resuscitation: a prospective clinica 1 15. Fatovich D, Prentice D, Dobb G. Magnesium in in-hospital cardiac arrest. 以红2邮 Kroesen G. Aubin M. Recom-16mm段到BmB人m trial to investigate the in 108 patients with out-of-hospital cardiac arrest. Resuscitation. 2001: 50- phate for refractory ventricular fibrillation 91. Lederer W. Lichtenberger C, Pechlaner C, Kinzl J, Kroesen G, Baubin M. 1Cm已 Pilot study of intravenous magnesium sulfate in refractory cardiac arrest: safety data and recommendations for activator during oul-of-hospital cardiac 118. Longstreth WT Jr, Fahrenbruch CE, Olsulka M. Walsh TR, Copass MK, 119. Siemkowicz E 93. Scholz KH, Hilmer T, Schuster S. Wojcik J, Kreuzer H, Tebbe U.Throm- 120. Brown Ce faith RF, Neely D, Hobson J, Mill uscitated patients with pulmonary embolism. Dtsch Mec coronary Wochenschr.1990:115:930-935 94. Klefisch F, et al. Praklinische ultima-ratio thrombolyse bei therap 21. Seaberg DC. Menegazzi JJ, Check B, MacLeod BA, Yealy DM. kardiopulmonaler reanimation. Intensivmedizin 5-162. 95. Tiffany PA, Schultz M, Stueven H. Bolus thrombolytic infusions during 122 ctory arrest rhythms: outcome of a agnesium reduces free radical concentration and preserves left ventric Thrombolytika in der Reanimation als Ultima ratio zur Uberwindung des 123. Ditchey RV, Lindenfeld J. Potential adverse effects of volum perfusion of vital organs during closed-chest resuscitation. Circulation behandlung.1991;16:134-1 le NT, Martin GB, Appleton TJ, Moeggenberg J, Paradis NA. Nowak coronary perfuse thrombolysis in patients with acute myocardial infarction requiring cardio- pressures during canine CPR Resuscitation. 1991: 22: 55-63 125. Jameson eek CA. Wanger KP, useless electrical activity. N Engl J Med. 2002 346: 1522-1528. taton.1987:15:11tained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. J Am Coll Cardiol. 1996;27:67–75. 77. Somberg JC, Bailin SJ, Haffajee CI, Paladino WP, Kerin NZ, Bridges D, Timar S, Molnar J. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am J Cardiol. 2002;90:853–859. 78. Somberg JC, Timar S, Bailin SJ, Lakatos F, Haffajee CI, Tarjan J, Paladino WP, Sarosi I, Kerin NZ, Borbola J, Bridges DE, Molnar J. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone. Am J Cardiol. 2004;93:576–581. 79. Paiva EF, Perondi MB, Kern KB, Berg RA, Timerman S, Cardoso LF, Ramirez JA. Effect of amiodarone on haemodynamics during cardiopul￾monary resuscitation in a canine model of resistant ventricular fibrillation. Resuscitation. 2003;58:203–208. 80. Borer JS, Harrison LA, Kent KM, Levy R, Goldstein RE, Epstein SE. Beneficial effect of lidocaine on ventricular electrical stability and spon￾taneous ventricular fibrillation during experimental myocardial infarction. Am J Cardiol. 1976;37:860–863. 81. Spear JF, Moore EN, Gerstenblith G. Effect of lidocaine on the ventricular fibrillation threshold in the dog during acute ischemia and premature ventricular contractions. Circulation. 1972;46:65–73. 82. Lie KI, Wellens HJ, van Capelle FJ, Durrer D. Lidocaine in the prevention of primary ventricular fibrillation: a double-blind, randomized study of 212 consecutive patients. N Engl J Med. 1974;291:1324–1326. 83. Herlitz J, Bang A, Holmberg M, Axelsson A, Lindkvist J, Holmberg S. Rhythm changes during resuscitation from ventricular fibrillation in relation to delay until defibrillation, number of shocks delivered and survival. Resuscitation. 1997;34:17–22. 84. Kentsch M, Berkel H, Bleifeld W. Intravenose Amiodaron-Applikation bei therapierefraktarem Kammerflimmern. Intensivmedizin. 1988;25:70–74. 85. Weaver WD, Fahrenbruch CE, Johnson DD, Hallstrom AP, Cobb LA, Copass MK. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation. 1990;82: 2027–2034. 86. Manz M, Pfeiffer D, Jung W, Lueritz B. Intravenous treatment with magnesium in recurrent persistent ventricular tachycardia. New Trends in Arrhythmias. 1991;7:437–442. 87. Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottlieb S, Stern S. Treatment of torsade de pointes with magnesium sulfate. Circulation. 1988;77:392–397. 88. Keren A, Tzivoni D, Gavish D, Levi J, Gottlieb S, Benhorin J, Stern S. Etiology, warning signs and therapy of torsade de pointes: a study of 10 patients. Circulation. 1981;64:1167–1174. 89. Bottiger BW, Bode C, Kern S, Gries A, Gust R, Glatzer R, Bauer H, Motsch J, Martin E. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet. 2001;357:1583–1585. 90. Lederer W, Lichtenberger C, Pechlaner C, Kroesen G, Baubin M. Recom￾binant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation. 2001;50: 71–76. 91. Lederer W, Lichtenberger C, Pechlaner C, Kinzl J, Kroesen G, Baubin M. Long-term survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest. Resuscitation. 2004;61:123–129. 92. Janata K, Holzer M, Kurkciyan I, Losert H, Riedmuller E, Pikula B, Laggner AN, Laczika K. Major bleeding complications in cardiopulmo￾nary resuscitation: the place of thrombolytic therapy in cardiac arrest due to massive pulmonary embolism. Resuscitation. 2003;57:49–55. 93. Scholz KH, Hilmer T, Schuster S, Wojcik J, Kreuzer H, Tebbe U. Throm￾bolysis in resuscitated patients with pulmonary embolism. Dtsch Med Wochenschr. 1990;115:930–935. 94. Klefisch F, et al. Praklinische ultima-ratio thrombolyse bei therapiere￾fraktarer kardiopulmonaler reanimation. Intensivmedizin. 1995;32: 155–162. 95. Tiffany PA, Schultz M, Stueven H. Bolus thrombolytic infusions during CPR for patients with refractory arrest rhythms: outcome of a case series. Ann Emerg Med. 1998;31:124–126. 96. Gramann J, Lange-Braun P, Bodemann T, Hochrein H. Der Einsatz von Thrombolytika in der Reanimation als Ultima ratio zur Überwindung des Herztodes. Intensiv-und Notfallbehandlung. 1991;16:134–137. 97. Ruiz-Bailen M, Aguayo de Hoyos E, Serrano-Corcoles MC, Diaz￾Castellanos MA, Ramos-Cuadra JA, Reina-Toral A. Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardio￾pulmonary resuscitation. Intensive Care Med. 2001;27:1050–1057. 98. Abu-Laban RB, Christenson JM, Innes GD, van Beek CA, Wanger KP, McKnight RD, MacPhail IA, Puskaric J, Sadowski RP, Singer J, Schechter MT, Wood VM. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med. 2002;346:1522–1528. 99. Hedges JR, Syverud SA, Dalsey WC, Feero S, Easter R, Shultz B. Pre￾hospital trial of emergency transcutaneous cardiac pacing. Circulation. 1987;76:1337–1343. 100. Barthell E, Troiano P, Olson D, Stueven HA, Hendley G. Prehospital external cardiac pacing: a prospective, controlled clinical trial. Ann Emerg Med. 1988;17:1221–1226. 101. Cummins RO, Graves JR, Larsen MP, Hallstrom AP, Hearne TR, Ciliberti J, Nicola RM, Horan S. Out-of-hospital transcutaneous pacing by emergency medical technicians in patients with asystolic cardiac arrest. N Engl J Med. 1993;328:1377–1382. 102. Stiell IG, Wells GA, Hebert PC, Laupacis A, Weitzman BN. Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs. Acad Emerg Med. 1995;2:264–273. 103. Lindner KH, Ahnefeld FW, Bowdler IM. Comparison of different doses of epinephrine on myocardial perfusion and resuscitation success during car￾diopulmonary resuscitation in a pig model. Am J Emerg Med. 1991;9: 27–31. 104. Befeler B. Mechanical stimulation of the heart; its therapeutic value in tachyarrhythmias. Chest. 1978;73:832–838. 105. Volkmann HK, Klumbies A, Kühnert H, Paliege R, Dannberg G, Siegert K. [Terminating ventricular tachycardias by mechanical heart stimulation with precordial thumps.] Z Kardiol. 1990;79:717–724. 106. Caldwell G, Millar G, Quinn E. Simple mechanical methods for cardio￾version: defence of the precordial thump and cough version. BMJ. 1985; 291:627–630. 107. Morgera T, Baldi N, Chersevani D, Medugno G, Camerini F. Chest thump and ventricular tachycardia. Pacing Clin Electrophysiol. 1979;2:69–75. 108. Rahner E, Zeh E. Die Regularisierung von Kammertachykardien durch präkordialen Faustschlag [The regularization of ventricular tachycardias by precordial thumping]. Medizinsche Welt. 1978;29:1659–1663. 109. Gertsch M, Hottinger S, Hess T. Serial chest thumps for the treatment of ventricular tachycardia in patients with coronary artery disease. Clin Cardiol. 1992;15:181–188. 110. Krijne R. Rate acceleration of ventricular tachycardia after a precordial chest thump. Am J Cardiol. 1984;53:964–965. 111. Sclarovsky S, Kracoff OH, Agmon J. Acceleration of ventricular tachycardia induced by a chest thump. Chest. 1981;80:596–599. 112. Yakaitis RW, Redding JS. Precordial thumping during cardiac resusci￾tation. Crit Care Med. 1973;1:22–26. 113. Thel MC, Armstrong AL, McNulty SE, Califf RM, O’Connor CM. Ran￾domised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet. 1997;350:1272–1276. 114. Allegra J, Lavery R, Cody R, Birnbaum G, Brennan J, Hartman A, Horowitz M, Nashed A, Yablonski M. Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting. Resusci￾tation. 2001;49:245–249. 115. Fatovich D, Prentice D, Dobb G. Magnesium in in-hospital cardiac arrest. Lancet. 1998;351:446. 116. Hassan TB, Jagger C, Barnett DB. A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation. Emerg Med J. 2002;19:57–62. 117. Miller B, Craddock L, Hoffenberg S, Heinz S, Lefkowitz D, Callender ML, Battaglia C, Maines C, Masick D. Pilot study of intravenous magnesium sulfate in refractory cardiac arrest: safety data and recommendations for future studies. Resuscitation. 1995;30:3–14. 118. Longstreth WT Jr, Fahrenbruch CE, Olsufka M, Walsh TR, Copass MK, Cobb LA. Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest. Neurology. 2002;59:506–514. 119. Siemkowicz E. Magnesium sulfate solution dramatically improves immediate recovery of rats from hypoxia. Resuscitation. 1997;35:53–59. 120. Brown CG, Griffith RF, Neely D, Hobson J, Miller B. The effect of intravenous magnesium administration on aortic, right atrial and coronary perfusion pressures during CPR in swine. Resuscitation. 1993;26:3–12. 121. Seaberg DC, Menegazzi JJ, Check B, MacLeod BA, Yealy DM. Use of a cardiocerebral-protective drug cocktail prior to countershock in a porcine model of prolonged ventricular fibrillation. Resuscitation. 2001;51: 301–308. 122. Zhang Y, Davies LR, Martin SM, Bawaney IM, Buettner GR, Kerber RE. Magnesium reduces free radical concentration and preserves left ventric￾ular function after direct current shocks. Resuscitation. 2003;56:199–206. 123. Ditchey RV, Lindenfeld J. Potential adverse effects of volume loading on perfusion of vital organs during closed-chest resuscitation. Circulation. 1984;69:181–189. 124. Gentile NT, Martin GB, Appleton TJ, Moeggenberg J, Paradis NA, Nowak RM. Effects of arterial and venous volume infusion on coronary perfusion pressures during canine CPR. Resuscitation. 1991;22:55–63. 125. Jameson SJ, Mateer JR, DeBehnke DJ. Early volume expansion during cardiopulmonary resuscitation. Resuscitation. 1993;26:243–250. 126. Voorhees WD, Ralston SH, Kougias C, Schmitz PM. Fluid loading with whole blood or Ringer’s lactate solution during CPR in dogs. Resusci￾tation. 1987;15:113–123. IV-66 Circulation December 13, 2005